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ccording  to  the  World  Health  Organization’s  world  health
eport  2004,  cerebral-vascular  disease  --  stroke  --  is  the  third
eading  cause  of  premature  death  in  both  genders.1 Its  great-
st  impact  is  represented  as  the  leading  cause  of  disability
n  adults  and  the  second  leading  cause  of  dementia.
Over  15  million  cases  of  stroke  occur  every  year  world-
ide,  one  case  every  6  s.  The  impact  of  the  disease  is  greater
n  developing  countries  (2  out  of  3  cases).  In  2005,  87%  of
he  5.7  deaths  by  cerebral-vascular  disease  were  in  lower
r  middle  socio-economic-level  countries.2 This  means  that
y  the  year  2020,  over  52  million  deaths  will  be  caused  by
trokes  in  developing  countries.3
In  Mexico,  according  to  the  National  Institute  of  Statis-
ics  and  Geography  (INEGI,  by  its  Spanish  acronym),  strokes
ere  the  sixth  leading  cause  of  death  in  2012,  just  after
eart  diseases,  diabetes  mellitus,  malign  tumors,  accidents
nd  liver  diseases.4 The  fact  that  it  registered  as  number
 may  seem  like  in  Mexico,  death  by  cerebral-vascular  dis-
ase  is  less  frequent.  However,  it  is  possible  that  when  it
ccurs  in  diabetic  patients  it  becomes  sub-registered.  This
an  be  explained  in  different  ways.  Approximately  30%  of
atients  who  suffer  a  stroke  have  comorbidities  with  other
iseases  of  cardiovascular  risk,  such  as  diabetes,  heart  dis-
ases,  hypertension  and  other  modiﬁable  risk  factors,  which
re  registered  as  the  main  cause  of  death  in  the  certiﬁcates
∗ Corresponding author at: Servicio de Neurología del Hospital Uni-
ersitario ‘‘Dr. José Eleuterio González’’, Universidad Autónoma de
uevo León, Av Francisco I. Madero S/N, Col. Mitras Centro, C.P.
4460 Monterrey, N.L., Mexico.
E-mail address: fernando.gongora@hotmail.com
m
c
t
c
ttp://dx.doi.org/10.1016/j.rmu.2015.04.001
665-5796/© 2015 Universidad Autónoma de Nuevo León. Published by M
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4n  our  country.  Another  explanation  is  the  lack  of  a  universal
erm  that  encompasses  the  whole  spectrum  of  the  disease.
or  example,  in  the  US  the  word  ‘‘stroke’’  includes  ischemic
ascular  disease  and  hemorrhagic  vascular  disease,  and  it  is
learly  separated  from  heart  disease.  In  Spain  a  single  term
s  used:  ‘‘ictus’’.  This  allows  them  to  have  global  numbers
f  the  disease.  In  Brazil,  it  is  known  as  the  second  leading
ause  of  death.  On  the  other  hand,  in  Mexico,  like  in  many
ther  countries  in  Latin  America,  there  is  no  clear  distinction
etween  the  diseases  involving  the  cardiovascular  system.
he  General  population  and  healthcare  personnel  use  many
‘similar’’  terms  to  refer  to  cerebral-vascular  disease,  or
troke,  like  embolism,  apoplexy,  brain  attack,  cerebral
nfarct,  cerebral  hemorrhage  and  cerebral-vascular  acci-
ent;  it  is,  in  many  cases,  even  generalized  as  ‘‘infarct’’,
ithout  specifying  whether  it  was  the  heart  or  the  brain.
his  causes  a  fragmentation  in  the  registry  of  the  disease,
hus  its  incorrect  representation  in  ofﬁcial  health  records.
Cerebral-vascular  disease  is  more  frequent  in  adults  and
ts  frequency  increases  signiﬁcantly  after  the  age  of  60;
owever,  it  may  occur  at  any  age.  The  reason  for  this
s  the  variety  of  etiologies,  ranging  from  genetic  causes,
etabolic  origin,  hematological  causes,  cardio-embolic  ori-
in,  atherosclerosis  and  even  some  caused  by  direct  trauma
ike  arterial  dissection;  thus,  age  does  not  represent  a
estriction  to  suffering  from  a  cerebral-vascular  disease.  For
xample,  children  with  sickle  cell  anemia  may  suffer  a  cere-
ral  infarction  during  the  ﬁrst  years  of  their  lives;  a  teenager
ay  suffer  a carotid  artery  trauma  during  a  car  accident,
ausing  a carotid  dissection  resulting  in  cerebral  infarc-
ion  by  occlusion  of  the  neck  vessels.  A  young  adult  with
ardiovascular  risk  factors  may  suffer  a  cerebral  infarction
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secondary  to  a  heart  paroxysmal  arrhythmia  caused  by  a thy-
roid  disorder,  or  even  by  a  defect  in  the  electric  conduction
to  the  myocardium;  lastly,  the  elderly  may  suffer  a  cerebral
infarct  caused  by  an  extra  atherosclerotic  or  intracranial
plaque  which  progressively  occludes  an  artery  that  irrigates
the  brain.  Therefore,  it  is  a  disease  which  affects  all  ages,
with  multiple  etiologies,  and  one  that  should  be  contem-
plated  by  the  Health  Sector  as  catastrophic  and  a  priority.
The  average  age  of  onset  of  cerebral-vascular  disease
is  65  years  of  age,  and  the  prevalence  and  incidence  of
the  disease  will  hopelessly  increase  with  the  demographic
change.  In  2004,  the  base  of  the  population  pyramid  is  nar-
rower  than  in  1990  due  to  the  fact  that  the  proportion  of
children  and  young  people  had  been  signiﬁcantly  reduced,
with  an  increase  from  6.2  to  9.7%  in  the  participation  of  the
elderly.  By  2050,  this  is  expected  to  increase  to  21.5%.5 The
increase  in  the  survival  rate  of  the  population  has  caused
most  deaths  to  occur  at  an  advanced  age.  For  example,  in
Mexico,  out  of  the  602,000  deaths  registered  in  2012,  61.9%
corresponded  to  people  over  60  years  of  age  and  older,  the
higher  percentage  of  mortality  reported  by  the  INEGI  in  2012
was  a  result  of  chronic  degenerative  diseases,  among  which
a  few  stand  out:  diabetes  mellitus  (16.9%),  ischemic  heart
diseases  (16.5%)  and  cerebral-vascular  diseases  (7%).4
Most  of  the  healthcare  information  registered  in  the
country  is  based  on  hospital  reports  and  death  certiﬁcates.
There  are  few  epidemiological  studies  based  on  communal
studies  designed  to  determine  the  prevalence  and  incidence
of  cerebral-vascular  disease  in  Mexico.6
Information  on  cerebral-vascular  disease  incidence  in
Mexico  results  from  a  door-to-door  study  called  BASID  (The
Brain  Attack  Surveillance  in  Durango),7 where  the  accumu-
lated  incidence  was  232.3  per  100,000  inhabitants  (IC  95%
27.8--436.9),  with  a  mean  sample  of  51.5  years  of  age  and
16%  subjects  over  65  years  of  age.
In  Latin  America,  the  variation  of  cerebral-vascular  dis-
ease  prevalence  is  wide.  In  Mexico,  estimations  suggest  6.7
per  1000  inhabitants  in  urban  areas  and  6.5  per  1000  in  rural
areas.8 In  the  BASID  study,  cerebral-vascular  disease  preva-
lence  was  7.7  per  1000  in  all  patients  and  18.2  per  1000  in
those  60  years  old  or  older.7
Cerebral-vascular  disease  mortality  rate  has  increased  in
Mexico,  while  the  mortality  rate  has  decreased  in  devel-
oped  countries,  like  in  the  US,  where  it  went  from  being
the  third  leading  cause  of  death  to  number  4,9 This  was
thanks  to  the  education  awareness  of  the  population,  early
detection  of  risk  factors,  and  the  implementation  of  spe-
cialty  hospital  services,  called  Stroke  Units.  In  Mexico,  in  the
year  2000,  435,386  deaths  by  cerebral-vascular  disease  were
registered,  with  an  annual  mortality  rate  of  25.21/100,000,
while  in  the  year  2008,  538,288  deaths  were  registered
with  an  annual  mortality  rate  of  28.3/100,000.10 In  2007,
cerebral-vascular  disease  was  the  fourth  cause  of  death  in
people  65  years  of  age  and  older,11 and  in  2012,  it  is  the  third
leading  cause  of  death  after  diabetes  and  heart  diseases.4
Global  CVD  mortality  rates  reported  in  some  hospital
records  in  the  country  range  from  19.6%  at  30  days  up  to
29%  at  one  year.  Cerebral  hemorrhage  reported  a  higher
mortality  rate  than  cerebral  infarction.6
The  most  commonly  associated  risk  factors  of  cerebral-
vascular  disease  in  our  country  are  high  blood  pressure
(65--70%),  diabetes  mellitus  (35--39%),  obesity  (50%),
r
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requent  consumption  of  alcohol  (16%),  smoking  (16--24%)
nd  dyslipidemia  (11%).7,12
Cerebral-vascular  disease  (CVD)  includes  ischemic  and
emorrhagic  CVD  and  cerebral  venous  thrombosis  (CVT).  At
he  same  time,  ischemic  CVD  includes  transient  ischemic
ttack  (TIA)  and  cerebral  infarction  (CI);  Hemorrhagic  CVD
ncludes  different  forms  of  intracranial  hemorrhage  (ICH),
uch  as  cerebral  hemorrhage  (CH)  and  subarachnoid  hem-
rrhage  (SAH),  excluding  those  hemorrhages  of  traumatic
tiology.  The  most  common  form  of  cerebral-vascular  dis-
ase  is  ischemic,  especially  cerebral  infarction  (≈60--80%).13
The  most  frequent  ischemic  CVD  etiology  in  Mexico  can-
ot  be  precisely  known,  due  to  the  fact  that  a  uniform
rotocol  of  attention  to  the  disease,  including  a  diagnostic
pproach,  does  not  exist  among  hospitals  in  this  coun-
ry.  This  is  unfortunate  because  the  secondary  prevention
reatment,  which  helps  to  avoid  a  recurrence,  depends  on
he  prompt  etiological  deﬁnition  of  the  cerebral  infarct.
or  example,  in  the  PREMIER  study,  the  etiological  mech-
nism  registered  to  cerebral  infarct  was:  8%  by  large  artery
therosclerosis,  20%  by  lacunar  infarction  or  by  small  vessel
isease,  20%  by  cardioembolism,  without  specifying  whether
r  not  it  was  atrial  ﬁbrillation,  5%  by  diverse  causes  and  41%
y  an  undeﬁned  etiology.13 It  is  evident  that  the  etiology
f  cerebral  infarction  is  deﬁned  as  the  necessary  laboratory
nd  clinical  studies  are  conducted.  In  the  2012  report  of
he  neurovascular  unit  of  the  University  Hospital  of  Mon-
errey,  39%  were  caused  by  large  artery  atherosclerosis,
7%  by  lacunar  infarction  or  by  small  vessel  disease,  13%
y  cardioembolism,  0.5%  by  arterial  dissection  and  24%  by
ndetermined  causes.14 These  differences  are  due  to  the
act  that  the  hospital  has  created  a  systematic  form  for  the
linical  and  laboratory  studies,  such  as  MRIs  (86%),  echocar-
iograms  (60%)  and  ultrasound  studies  of  the  arteries  of  the
eck  (75%),  during  the  patient’s  stay  in  the  acute  stage  of
he  stroke,  while  in  the  PREMIER  study  (the  ﬁrst  multicenter
tudy  in  Mexico)  an  MRI  was  performed  on  24%,  an  echocar-
iogram  on  15%  and  a  carotid  ultrasound  study  on  20%  of  the
atients  registered  with  a  stroke.  Despite  the  high  percent-
ge  of  cases  without  an  etiological  deﬁnition,  the  rate  of
ecurrence  of  cerebral  ischemia  was  8%  annually,12 and  50%
ccurred  in  the  ﬁrst  month  after  the  initial  event.
The  functional  incapacity  after  an  ictus  for  cerebral
ascular  event  is  a consequence  of  the  extent  of  the  cere-
ral  damage.  For  example,  in  the  evolution  of  a  stroke,
f  the  treatment  is  begun  as  early  as  possible  and  is  able
o  reestablish  cerebral  circulation  before  the  ﬁrst  3  h  of
he  evolution,  functional  and  neurological  recuperation  will
e  very  satisfactory.  In  Mexico’s  registers,  between  24  and
9%  of  patients  are  left  with  moderate  to  severe  functional
ependency  at  30  days  of  follow-up.  The  greater  degree
f  functional  damage  is  felt  by  patients  in  rural  areas,  as
pposed  to  urban,8,15 possibly  due  to  incomplete  medical
ttention  and  the  lesser  exposure  of  new  treatments  in  rural
reas.
Another  reason  why  the  health  priority  that  CVD  repre-
ents  is  underestimated  is  a lack  of  complete  analysis  of
he  costs.  In  Mexico,  the  hospital  costs  are  less  than  those
eported  by  other  countries  like  the  United  States,  Spain
r  Brazil.  However,  the  true  cause  seems  to  be  the  greater
ortality  rate  and  the  lack  of  diagnostic  approach  studies
ade  in  our  hospitals,  causing  the  lack  of  deﬁnition  of  the
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186  
tiology,  thus  the  administration  of  a  medication  which  is
ess-effective  in  avoiding  recurrence.  On  the  other  hand,
he  indirect  cost  of  a  patient  with  neurological  sequelae  and
unctional  dependence  is  enormous,  especially  if  we  con-
ider  long-term  care,  rehabilitation,  the  loss  of  productive
apacity  and  the  impact  on  the  family  economy.
The  ﬁrst  step  in  the  chain  of  events  that  lets  us  treat  a
atient  with  a  cerebral-vascular  event  opportunely  is  the
ecognition  of  the  alarm  symptoms  and  the  necessity  of
oving  the  patient  to  a  hospital  center  immediately.2 The
exican  population  does  not  know  the  alarm  signs  of  a
erebral-vascular  event.  For  example,  in  Mexico  City  it  was
ound  that  37%  of  the  population  recognized  an  alarm  symp-
om  such  as  weakness  in  an  arm  or  leg,  deviation  of  the
outh  or  difﬁculty  speaking,  but  only  2.1%  could  name  3  or
ore  clinical  manifestations.  This  evidences  the  necessity  of
aking  massive  education  campaigns  with  the  information
hat  would  permit  the  population  to  identify  the  manifes-
ations  of  a  cerebral-vascular  event  and  permit  the  urgent
ransportation  to  a  hospital.16,17
Current  treatment  has  changed  the  panorama  of  CVD,
specially  cerebral  infarcts.  Since  1995,  it  has  been  known
hat  the  treatment  called  thrombolysis  allows  patients  who
mmediately  go  to  a  hospital  to  receive  an  intravenous  med-
cation  which  recanalize  the  occluded  artery  and  which  can
ometimes  achieve  a  complete  recovery  in  the  neurological
unctions  of  the  patient.  The  time  in  which  this  medication
an  be  appiled  is  only  4-and-a-half  hours  from  the  onset  of
ymptoms.  Nevertheless,  its  use  has  changed  the  way  we
ee  ischemic  CVD  and  opened  the  hope  of  medical  recu-
eration  for  the  patient.  Because  of  this,  it  is  a  priority
o  annouce  to  the  public  that  they  must  get  to  a  hospital
uickly  if  they  notice  signs  of  ischemic  stroke,  and  ask  the
octors  and  authorities  to  prepare  to  offer  this  alternative
reatment  in  national  hospitals.
There  have  been  some  efforts  made  to  improve  the
ublic’s  knowledge  of,  and  the  hospitals’  attention  to,
his  disease  in  Mexico.  National  and  international  scientiﬁc
eetings  have  been  organized,  generating  collaboration
nitiatives  between  national  societies  like  the  Mexican
eurological  Academy  and  the  Mexican  Association  of
erebral-Vascular  Disease,  and  other  international  associ-
tions  like  the  Iberoamerican  Society  of  Cerebrovascular
isease,  the  American  Academy  of  Neurology  and  the  World
ederation  of  Neurology.  In  2010  the  ﬁrst  Neurovascular
nits  were  inaugurated  in  Mexico,  although,  to  this  day,  the
nly  one  that  has  survived  the  passage  of  time  has  been
he  one  at  the  University  Hospital  of  the  city  of  Monter-
ey,  thanks  to  the  aid  of  the  local  authorities.  On  October
9th,  ‘‘World  Cerebral-Vascular  Disease  Day’’  in  2012,  the
tate  of  Nuevo  Leon  won  ﬁrst  place  in  the  World  Stroke  Cam-
aign  of  the  World  Stroke  Organization  with  the  Campaign
f  Education  and  Diffusion  against  Cerebral  Attacks,  made
ith  the  aid  of  the  Secretary  of  Health.  Other  states  of
exico  have  added  to  the  effort  of  working  toward  this  pro-
osal,  highlighting  the  states  of  Querétaro,  Sinaloa,  Jalisco,
hiapas  and  the  Federal  District,  with  education  programs
nd  training  for  medical  personnel  and  paramedics  on  pre-
ospitalization  attention.  In  the  framework  of  the  Annual
eeting  of  the  Mexican  Neurological  Academy  in  November
f  2013,  the  Merida  Declaration  was  made,  where  a  commit-
ent  was  signed  between  medical  societies  to  work  together
1F.  Góngora-Rivera
ith  the  states  of  Mexico  to  improve  the  means  of  educa-
ion,  prevention  and  medical  and  paramedical  attention,  as
ell  as  the  rehabilitation  services  of  cerebral-vascular  dis-
ase.  However,  in  spite  of  all  these  efforts,  the  impact  on  the
ecovery  of  the  patient  with  a  cerebral-vascular  event  has
een  minimal.  We  believe  that  the  only  way  to  change  and
mprove  the  prognosis  of  patients  with  a  cerebral-vascular
vent  or  Stroke  is  to  guarantee  their  management  with
ational  health  coverage.  We  must  develop  a strategic  plan
or  universal  coverage  of  CVD  through  educational  programs,
rganization  of  pre-hospitalization  attention,  and  growth
f  the  medical  infrastructure  with  the  support  of  authori-
ies  and  the  Goverment,  which  will  allow  us  to  access  the
reatments  which  have  been  scientiﬁcally  demonstrated  to
hange  the  functional  prognosis  of  the  patient.
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